Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
IRVING, Texas, Dec. 31, 2025 (GLOBE NEWSWIRE) -- As 2025 ends, BioNTX reflects on a year—and the close of the first quarter of the 21st century—defined by accelerated growth, expanded engagement,...
-
Nutriband New Year Letter to Shareholders
-
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
-
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
-
-
Fentanyl designation Response
-
Dublin, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The "Medication Side-Effect Tracker App Global Market Report 2025" has been added to ResearchAndMarkets.com's offering.The medication side-effect tracker...
-
Dublin, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The "Pharma Supply Chain & Security World 2026 (London, United Kingdom - Mar 18th - Mar 19th, 2026)" has been added to ResearchAndMarkets.com's...
-
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries Prospective clinical data show NexoBrid® removes...
-
Boston, Dec. 09, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Separation Systems for Commercial Biotechnology” is projected to grow from $32.5 billion in 2025 to $45.1...